PROGNOSIS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER RECEIVED CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB (CPB).: Abstract ID – 137


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles